Mila Tartakovsky Bio
Mila Tartakovsky
As Head of US Finance and Global Oncology Finance, Mila is responsible for evaluating the operating performance, focusing on achieving profitable growth and supporting the long-term strategic vision of Daiichi Sankyo. Specifically, Mila leads the team of finance business partners, providing financial guidance to the Oncology Business Unit in Europe and US, supporting key operational and strategic decisions of the OBU. In addition, Mila is responsible for overseeing the financial affairs of Daiichi Sankyo in the US. including timely financial close, regulatory filings, J-SOX compliance, and ensuring the integrity and compliance of all financial and regulatory reporting; She is responsible for leading Corporate Procurement team, providing the business strategic support in supplier selection and management; She also leads Corporate Programs, Events, and Facilities teams.
Prior to joining Daiichi Sankyo, Mila has had extensive experience in both public accounting and equity research. Through various roles in finance, Mila has remained steadfast in her focus on delivering transparent results and achieving business goals through inclusive leadership and business collaboration.
Mila is motivated when helping foster a positive impact on others. No matter the extent of the challenge, Mila is passionate about contributing toward improving the needs of the organization to allow for a patient focus, which inspires her energy and enthusiasm to effectively lead her team.